NASDX | RGACX | NASDX / RGACX | |
Total Expense Ratio | 0.51 | 0.94 | 54% |
Annual Report Gross Expense Ratio | 0.64 | 0.94 | 68% |
Fund Existence | 26 years | 23 years | - |
Gain YTD | 12.796 | 15.516 | 82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.01B | 332B | 1% |
Annual Yield % from dividends | 0.26 | 0.07 | 367% |
Returns for 1 year | 15.68 | 17.83 | 88% |
Returns for 3 years | 66.44 | 58.53 | 114% |
Returns for 5 years | 67.84 | 40.02 | 170% |
Returns for 10 years | 313.41 | 95.93 | 327% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AASOX | 17.88 | 0.24 | +1.36% |
Alger Small Cap Growth I-2 | |||
ETCHX | 35.00 | N/A | N/A |
Eventide Healthcare & Life Sciences C | |||
ADCCX | 18.12 | N/A | N/A |
American Century Disciplined Growth C | |||
ASVGX | 10.68 | -0.03 | -0.28% |
American Century Small Cap Value R5 | |||
TRSPX | 70.59 | -0.21 | -0.30% |
Nuveen S&P 500 Index Retire |